Secretion of amyloid precursor protein via signal transduction pathway
Secretion of amyloid precursor protein via signal transduction pathway
批准号:
06454705
负责人:
ISHIURA Shoichi
金额:
$4.03万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
阿尔茨海默病(AD)的特点是进行性神经变性。AD的特征之一是形成老年斑,其中主要含有β蛋白,这是一种由大膜结合的淀粉样前体蛋白(APP)加工而成的小肽,由39-43个氨基酸残基组成。在AD大脑中,APP通过异常处理转换为β蛋白,而几乎所有的APP通常都是在属于β蛋白分子的氨基酸16处的前体被裂解后分泌出来的。这种断裂也导致残存的C-末端非淀粉样蛋白10 kDa片段保留在膜内。为了研究APP的细胞内分选和加工的机制,我们通过定点突变的方法删除了APP的两个潜在的N-连接糖基化位点,即G蛋白结合位点、内小体滞留信号和溶酶体靶向信号。将野生型APPS和突变型APPS在COS-1细胞中表达,观察到蛋白产物的表达和N末端大片段的分泌。与野生型相比,突变型APP的初始分泌较慢,而PKC转染组的APP分泌量明显高于未转染组。这些结果表明,PKC通过一条信号通路调节APP的分泌。
英文摘要
Alzheimer's disease (AD) is characterized by progressive neurodegeneration. One of the features of AD is the formation of senile plaques, which contain mainly beta protein, small peptides comprising 39-43 amino acid residues, processed from a large membrane-bound amyloid precursor protein (APP). In AD brain, APP is converted to beta protein by abnormal processing, while almost all APP is normally secreted following cleavage of the precursor at amino acid 16 which falls within the beta protein molecule. This scission also leads to the retention of the residual C-terminal non-amyloidogenic 10 kDa fragment within the membrane. The regulation of beta protein formation by aberrant processing or of a secreted form by constitutive processing from the intact APP molecule remains unclear.In order to study the mechanism of intracellular sorting and processing of the APP,we deleted two potential N-linked glycosylation sites, G-protein binding site, endosome-retension signal and lysosome-targeting signal of APP by site-directed mutagenesis. Wild-type and mutant APPs were expressed in COS-1 cells by cDNA transfection and the expression of the protein products and secretion of N-terminal large fragment was observed. The initial secretion of the mutant APP appeared to be slow compared with wild type.The amount of APP secreted from PKC-transfected cells was higher than those from untransfected. These results suggest that PKC regulates the secretion of APP through a signaling pathway.
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Yoshizawa,他: "A catalytic subunit of calpain possesses full proteolytic activity." FEBS Lett.358. 101-103 (1995)
T. Yoshizawa 等人:“钙蛋白酶的催化亚基具有完整的蛋白水解活性。” FEBS Lett.358 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Kinouchi,他: "cPKα and nPKε,but notδ,increase APP secretion from PKC cDNA transfected fibroblasts treated with TPA." FEBS Lett.364. 203-206 (1995)
T. Kinouchi 等人:“cPKα 和 nPKε,但不是 δ,增加了经 TPA 处理的 PKC cDNA 转染的成纤维细胞的 APP 分泌。” FEBS Lett.364 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kinbara,k.et al.: "Processing and secretion of the amyloid precursor protein." Tohoku J.Exp.Med.174. 209-216 (1994)
Kinbara,k.et al.:“淀粉样前体蛋白的加工和分泌。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Maruyma, K. ,: "Secretion of Alzheimer β/A4 protein(1-40)and intracellular retention β/A4 protein (1-42) in transfected COS cells." Biochem. Biophys. Res. Commum.207. 971-977 (1995)
Maruyma,K.,“转染 COS 细胞中阿尔茨海默病 β/A4 蛋白 (1-40) 和细胞内滞留 β/A4 蛋白 (1-42) 的分泌。Biochem.207。” (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Development and use of amyloid secretase modulators in Alzhaimer's disease.
-
批准号:13210027
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$41.73万
-
财政年份:2001
-
负责人:ISHIURA Shoichi
-
依托单位:
Shedding activity and physiological role of a newly-found ADAM family metalloprotease family
-
批准号:13480202
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.8万
-
财政年份:2001
-
负责人:ISHIURA Shoichi
-
依托单位:
Isolation of signal molecules on the secretion of amyloid precursor
-
批准号:08458259
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1996
-
负责人:ISHIURA Shoichi
-
依托单位:
Role of dystrophin-related protein in the pathogenesis of Duchenne muscular dystrophy.
-
批准号:04670508
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.45万
-
财政年份:1992
-
负责人:ISHIURA Shoichi
-
依托单位:
Studies on the mechanism of Cytotoxic T-lymphocyte (CTL)-mediated muscle breakdown
-
批准号:62570123
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1987
-
负责人:ISHIURA Shoichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: